United States OTC Drug Market Report 2016

United States OTC Drug Market Report 2016

1 OTC Drug Overview

1.1 Product Overview and Scope of OTC Drug

1.2 Classification of OTC Drug

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of OTC Drug

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 USA Market Size Sales (Value) and Revenue (Volume) of OTC Drug (2011-2021)

1.4.1 USA OTC Drug Sales and Growth Rate (2011-2021)

1.4.2 USA OTC Drug Revenue and Growth Rate (2011-2021)

2 USA OTC Drug Competition by Manufacturers

2.1 USA OTC Drug Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA OTC Drug Revenue and Share by Manufactures (2015 and 2016)

2.3 USA OTC Drug Average Price by Manufactures (2015 and 2016)

2.4 OTC Drug Market Competitive Situation and Trends

2.4.1 OTC Drug Market Concentration Rate

2.4.2 OTC Drug Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 USA OTC Drug Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 USA OTC Drug Sales and Market Share by Type (2011-2016)

3.2 USA OTC Drug Revenue and Market Share by Type (2011-2016)

3.3 USA OTC Drug Price by Type (2011-2016)

3.4 USA OTC Drug Sales Growth Rate by Type (2011-2016)

4 USA OTC Drug Sales (Volume) by Application (2011-2016)

4.1 USA OTC Drug Sales and Market Share by Application (2011-2016)

4.2 USA OTC Drug Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 USA OTC Drug Manufacturers Profiles/Analysis

5.1 Bayer HealthCare

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 OTC Drug Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Bayer HealthCare OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 GlaxoSmithKline (GSK)

5.2.2 OTC Drug Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 GlaxoSmithKline (GSK) OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Johnson & Johnson

5.3.2 OTC Drug Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Johnson & Johnson OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Pfizer

5.4.2 OTC Drug Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Pfizer OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Sanofi

5.5.2 OTC Drug Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Sanofi OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 AstraZeneca

5.6.2 OTC Drug Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 AstraZeneca OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 BioGaia

5.7.2 OTC Drug Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 BioGaia OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Bristol Myers Squibb

5.8.2 OTC Drug Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Bristol Myers Squibb OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Bukwang Pharmaceutica

5.9.2 OTC Drug Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Bukwang Pharmaceutica OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Chr. Hansen

5.10.2 OTC Drug Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Chr. Hansen OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Cipla

5.12 CoLucid

5.13 Daiichi Sankyo

5.14 Dr. Reddy's Laboratories

5.15 DSM

5.16 Eisai

5.17 Eli Lilly

5.18 EMS

5.19 Euradite

5.20 Friggs

5.21 Genomma Lab Internacional

5.22 Glanbia

5.23 Herbalife

6 OTC Drug Manufacturing Cost Analysis

6.1 OTC Drug Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of OTC Drug

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 OTC Drug Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of OTC Drug Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 USA OTC Drug Market Forecast (2016-2021)

10.1 USA OTC Drug Sales, Revenue Forecast (2016-2021)

10.2 USA OTC Drug Sales Forecast by Type (2016-2021)

10.3 USA OTC Drug Sales Forecast by Application (2016-2021)

10.4 OTC Drug Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of OTC Drug

Table Classification of OTC Drug

Figure USA Sales Market Share of OTC Drug by Type in 2015

Table Application of OTC Drug

Figure USA Sales Market Share of OTC Drug by Application in 2015

Figure USA OTC Drug Sales and Growth Rate (2011-2021)

Figure USA OTC Drug Revenue and Growth Rate (2011-2021)

Table USA OTC Drug Sales of Key Manufacturers (2015 and 2016)

Table USA OTC Drug Sales Share by Manufacturers (2015 and 2016)

Figure 2015 OTC Drug Sales Share by Manufacturers

Figure 2016 OTC Drug Sales Share by Manufacturers

Table USA OTC Drug Revenue by Manufacturers (2015 and 2016)

Table USA OTC Drug Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA OTC Drug Revenue Share by Manufacturers

Table 2016 USA OTC Drug Revenue Share by Manufacturers

Table USA Market OTC Drug Average Price of Key Manufacturers (2015 and 2016)

Figure USA Market OTC Drug Average Price of Key Manufacturers in 2015

Figure OTC Drug Market Share of Top 3 Manufacturers

Figure OTC Drug Market Share of Top 5 Manufacturers

Table USA OTC Drug Sales by Type (2011-2016)

Table USA OTC Drug Sales Share by Type (2011-2016)

Figure USA OTC Drug Sales Market Share by Type in 2015

Table USA OTC Drug Revenue and Market Share by Type (2011-2016)

Table USA OTC Drug Revenue Share by Type (2011-2016)

Figure Revenue Market Share of OTC Drug by Type (2011-2016)

Table USA OTC Drug Price by Type (2011-2016)

Figure USA OTC Drug Sales Growth Rate by Type (2011-2016)

Table USA OTC Drug Sales by Application (2011-2016)

Table USA OTC Drug Sales Market Share by Application (2011-2016)

Figure USA OTC Drug Sales Market Share by Application in 2015

Table USA OTC Drug Sales Growth Rate by Application (2011-2016)

Figure USA OTC Drug Sales Growth Rate by Application (2011-2016)

Table Bayer HealthCare Basic Information List

Table Bayer HealthCare OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Bayer HealthCare OTC Drug Sales Market Share (2011-2016)

Table GlaxoSmithKline (GSK) Basic Information List

Table GlaxoSmithKline (GSK) OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table GlaxoSmithKline (GSK) OTC Drug Sales Market Share (2011-2016)

Table Johnson & Johnson Basic Information List

Table Johnson & Johnson OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Johnson & Johnson OTC Drug Sales Market Share (2011-2016)

Table Pfizer Basic Information List

Table Pfizer OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Pfizer OTC Drug Sales Market Share (2011-2016)

Table Sanofi Basic Information List

Table Sanofi OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sanofi OTC Drug Sales Market Share (2011-2016)

Table AstraZeneca Basic Information List

Table AstraZeneca OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table AstraZeneca OTC Drug Sales Market Share (2011-2016)

Table BioGaia Basic Information List

Table BioGaia OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table BioGaia OTC Drug Sales Market Share (2011-2016)

Table Bristol Myers Squibb Basic Information List

Table Bristol Myers Squibb OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bristol Myers Squibb OTC Drug Sales Market Share (2011-2016)

Table Bukwang Pharmaceutica Basic Information List

Table Bukwang Pharmaceutica OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bukwang Pharmaceutica OTC Drug Sales Market Share (2011-2016)

Table Chr. Hansen Basic Information List

Table Chr. Hansen OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Chr. Hansen OTC Drug Sales Market Share (2011-2016)

Table Cipla Basic Information List

Table Cipla OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Cipla OTC Drug Sales Market Share (2011-2016)

Table CoLucid Basic Information List

Table CoLucid OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table CoLucid OTC Drug Sales Market Share (2011-2016)

Table Daiichi Sankyo Basic Information List

Table Daiichi Sankyo OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Daiichi Sankyo OTC Drug Sales Market Share (2011-2016)

Table Dr. Reddy's Laboratories Basic Information List

Table Dr. Reddy's Laboratories OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Dr. Reddy's Laboratories OTC Drug Sales Market Share (2011-2016)

Table DSM Basic Information List

Table DSM OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table DSM OTC Drug Sales Market Share (2011-2016)

Table Eisai Basic Information List

Table Eisai OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Eisai OTC Drug Sales Market Share (2011-2016)

Table Eli Lilly Basic Information List

Table Eli Lilly OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Eli Lilly OTC Drug Sales Market Share (2011-2016)

Table EMS Basic Information List

Table EMS OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table EMS OTC Drug Sales Market Share (2011-2016)

Table Euradite Basic Information List

Table Euradite OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Euradite OTC Drug Sales Market Share (2011-2016)

Table Friggs Basic Information List

Table Friggs OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Friggs OTC Drug Sales Market Share (2011-2016)

Table Genomma Lab Internacional Basic Information List

Table Genomma Lab Internacional OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Genomma Lab Internacional OTC Drug Sales Market Share (2011-2016)

Table Glanbia Basic Information List

Table Glanbia OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Glanbia OTC Drug Sales Market Share (2011-2016)

Table Herbalife Basic Information List

Table Herbalife OTC Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Herbalife OTC Drug Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of OTC Drug

Figure Manufacturing Process Analysis of OTC Drug

Figure OTC Drug Industrial Chain Analysis

Table Raw Materials Sources of OTC Drug Major Manufacturers in 2015

Table Major Buyers of OTC Drug

Table Distributors/Traders List

Figure USA OTC Drug Production and Growth Rate Forecast (2016-2021)

Figure USA OTC Drug Revenue and Growth Rate Forecast (2016-2021)

Table USA OTC Drug Production Forecast by Type (2016-2021)

Table USA OTC Drug Consumption Forecast by Application (2016-2021)